Back to the main directory
Press Release
- Altimmune Appoints Raymond Jordt as Chief Business Officer by GlobeNewsWire
- Myriad Genetics to Present at 41st Annual J.P. Morgan Healthcare Conference by GlobeNewsWire
- Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 7, 2023 by GlobeNewsWire
- Akero Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference by GlobeNewsWire
- Eagle Bulk Shipping Inc. Completes Transfer of Listing to the New York Stock Exchange by GlobeNewsWire
- Checkpoint Therapeutics Submits Biologics License Application to FDA for Cosibelimab as a Treatment for Patients with Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma by GlobeNewsWire
- FOREWARN Partners with Columbus REALTORS® by GlobeNewsWire
- Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada by GlobeNewsWire
- Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
- Replimune Appoints Former Sanofi U.S. Commercial Oncology Head, Chris Sarchi, as Chief Commercial Officer and Sushil Patel as Chief Strategy Officer by GlobeNewsWire
- Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference by GlobeNewsWire
- Tonix Pharmaceuticals Appoints Zeil Rosenberg, M.D., M.P.H., as Executive Vice President, Medical for Infectious Disease Programs by GlobeNewsWire
- Verrica Pharmaceuticals Announces the Successful Technology Transfer of Bulk Solution Manufacturing of VP-102 to Piramal Pharma Solutions by GlobeNewsWire
- Oncorus Announces Research Collaboration with Daewoong Pharmaceutical for the Development of Lipid Nanoparticle Formulations for mRNA Drug Candidates by GlobeNewsWire
- Fairfax Declares Annual Dividend by GlobeNewsWire
- Annexon to Present at 41st Annual J.P. Morgan Healthcare Conference by GlobeNewsWire
- IGC Receives No Objection Letter from Health Canada by GlobeNewsWire
- Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD by GlobeNewsWire
- Akoustis Acquires GDSI, a US-Based, Trusted Supplier of Premium Semiconductor Back-End Supply Chain Services by GlobeNewsWire
- LifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Company’s Rapid Expansion into Virtual Primary Care by GlobeNewsWire
- Roivant Announces Statistically Significant and Clinically Meaningful Results from the Induction Period of TUSCANY-2, a Large Global Phase 2b Study of Subcutaneous RVT-3101 for the Treatment of Ulcerative Colitis in Both the Overall and the Biomarker Posi by GlobeNewsWire
- HP at CES 2023: Leading in Hybrid and Gaming Experiences by GlobeNewsWire
- Marathon Gold Announces Exploration Priorities During Valentine Mine Construction by GlobeNewsWire
- Ideal Power to Participate at Needham 25th Annual Growth Conference on January 12, 2023 by GlobeNewsWire
- Exploration Brunswick fournit une mise à jour de la société by GlobeNewsWire